Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 15,839 | 19,166 | 27,076 | 21,802 | 25,285 |
| Operating Income | -15,839 | -19,166 | -27,076 | -21,802 | -25,285 |
| Other Income | 6,738 | 430 | 353 | 561 | 964 |
| Pre-tax Income | -9,101 | -18,736 | -26,723 | -21,241 | -24,321 |
| Net Income Continuous | -9,101 | -18,736 | -26,723 | -21,241 | -24,321 |
| Net Income | $-9,101 | $-18,736 | $-26,723 | $-21,241 | $-24,321 |
| EPS Basic Total Ops | 0.33 | -1.13 | -1.74 | -1.41 | -1.65 |
| EPS Basic Continuous Ops | 0.33 | -1.13 | -1.74 | -1.41 | -1.64 |
| EPS Diluted Total Ops | 0.33 | -1.13 | -1.74 | -1.41 | -1.65 |
| EPS Diluted Continuous Ops | 0.33 | -1.13 | -1.74 | -1.41 | -1.64 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -1.13 | -1.74 | -1.41 | -1.62 |
| EBITDA(a) | $-15,549 | $-18,937 | $-26,818 | $-21,523 | $-25,040 |